39444090|t|The Activation of PKM2 Induces Pyroptosis in Hippocampal Neurons via the NLRP3/Caspase-1/GSDMD Pathway in Neonatal Rats With Hypoxic-Ischemic Brain Injury.
39444090|a|INTRODUCTION: The presence of hypoxic-ischemic brain damage (HIBD) in neonates triggers a strong neuroinflammatory reaction. Pyroptosis, a programmed cell death mechanism associated with inflammation, plays a crucial role in HIBD. Pyruvate kinase M2 (PKM2) plays a significant role in connecting metabolic processes and inflammatory responses, but whether it affects hippocampus pyroptosis in HIBD is unclear. The aim of this study is to elucidate the role of PKM2 in HIBD and to propose a novel therapeutic approach for neonatal ischemic-hypoxic encephalopathy. METHODS: In this study, we employed neonatal 7-day-old Sprague Dawley rats to establish a model of HIBD using the Rice-Vannucci surgical technique and a hypoxia device. To inhibit the elevation of PKM2, we utilized the PKM2 inhibitor shikonin. The rats were categorized into four groups: Sham, Shikonin, HIBD, and Shikonin + HIBD. Behavioral tests, hematoxylin eosin staining, immunofluorescence staining, ELISA (IL-1beta, IL-18), and LDH were conducted in each group to evaluate neurological function, hippocampal damage, the occurrence of neuronal pyroptosis, and the neuroinflammation. Western blot was used to assess the expression levels of PKM2, NLRP3, Caspase-1, Cleaved Caspase-1, GSDMD, GSDMDN, and IL-1beta. RESULTS: The expression of PKM2 elevated in hippocampal tissues of the HIBD model and the localization of PKM2 in the hippocampus was activated in neurons instead of microglia during the HIBD. Meanwhile, the inhibition of PKM2 improved the behavioral test scores and the body weight of rats, the neuronal damage in the CA1 region of hippocampal tissue was also attenuated. In addition, inhibiting PKM2 alleviated neuronal pyroptosis by decreasing the expression of PKM2, NLRP3, Caspase-1, Cleaved Caspase-1, GSDMD, GSDMDN. Furthermore, serum levels of LDH and inflammatory factors IL-1beta and IL-18 decrease with PKM2 inhibition. CONCLUSIONS: Based on these findings, we can conclude that PKM2 plays a crucial role in regulating hippocampal neuronal pyroptosis of HIBD rats via NLRP3/Caspase-1/GSDMD pathway. Therefore, inhibiting PKM2 could be a promising therapeutic strategy for the treatment of neonatal ischemic-hypoxic encephalopathy.
39444090	18	22	PKM2	Gene	25630
39444090	31	41	Pyroptosis	Disease	
39444090	73	78	NLRP3	Gene	287362
39444090	79	88	Caspase-1	Gene	25166
39444090	89	94	GSDMD	Gene	315084
39444090	115	119	Rats	Species	10116
39444090	125	154	Hypoxic-Ischemic Brain Injury	Disease	MESH:D020925
39444090	186	215	hypoxic-ischemic brain damage	Disease	MESH:D002534
39444090	217	221	HIBD	Disease	MESH:D002534
39444090	253	270	neuroinflammatory	Disease	MESH:D000090862
39444090	281	291	Pyroptosis	Disease	
39444090	343	355	inflammation	Disease	MESH:D007249
39444090	381	385	HIBD	Disease	MESH:D002534
39444090	387	405	Pyruvate kinase M2	Gene	25630
39444090	407	411	PKM2	Gene	25630
39444090	476	488	inflammatory	Disease	MESH:D007249
39444090	535	545	pyroptosis	Disease	
39444090	549	553	HIBD	Disease	MESH:D002534
39444090	616	620	PKM2	Gene	25630
39444090	624	628	HIBD	Disease	MESH:D002534
39444090	677	717	neonatal ischemic-hypoxic encephalopathy	Disease	MESH:D020925
39444090	789	793	rats	Species	10116
39444090	818	822	HIBD	Disease	MESH:D002534
39444090	872	879	hypoxia	Disease	MESH:D000860
39444090	916	920	PKM2	Gene	25630
39444090	938	942	PKM2	Gene	25630
39444090	953	961	shikonin	Chemical	MESH:C016101
39444090	967	971	rats	Species	10116
39444090	1013	1021	Shikonin	Chemical	MESH:C016101
39444090	1023	1027	HIBD	Disease	MESH:D002534
39444090	1033	1041	Shikonin	Chemical	MESH:C016101
39444090	1044	1048	HIBD	Disease	MESH:D002534
39444090	1132	1140	IL-1beta	Gene	24494
39444090	1142	1147	IL-18	Gene	29197
39444090	1222	1240	hippocampal damage	Disease	MESH:D000092223
39444090	1260	1279	neuronal pyroptosis	Disease	MESH:D009410
39444090	1289	1306	neuroinflammation	Disease	MESH:D000090862
39444090	1365	1369	PKM2	Gene	25630
39444090	1371	1376	NLRP3	Gene	287362
39444090	1378	1387	Caspase-1	Gene	25166
39444090	1397	1406	Caspase-1	Gene	25166
39444090	1408	1413	GSDMD	Gene	315084
39444090	1427	1435	IL-1beta	Gene	24494
39444090	1464	1468	PKM2	Gene	25630
39444090	1508	1512	HIBD	Disease	MESH:D002534
39444090	1543	1547	PKM2	Gene	25630
39444090	1624	1628	HIBD	Disease	MESH:D002534
39444090	1659	1663	PKM2	Gene	25630
39444090	1723	1727	rats	Species	10116
39444090	1733	1748	neuronal damage	Disease	MESH:D009410
39444090	1834	1838	PKM2	Gene	25630
39444090	1850	1869	neuronal pyroptosis	Disease	MESH:D009410
39444090	1902	1906	PKM2	Gene	25630
39444090	1908	1913	NLRP3	Gene	287362
39444090	1915	1924	Caspase-1	Gene	25166
39444090	1934	1943	Caspase-1	Gene	25166
39444090	1945	1950	GSDMD	Gene	315084
39444090	1997	2009	inflammatory	Disease	MESH:D007249
39444090	2018	2026	IL-1beta	Gene	24494
39444090	2031	2036	IL-18	Gene	29197
39444090	2051	2055	PKM2	Gene	25630
39444090	2127	2131	PKM2	Gene	25630
39444090	2179	2198	neuronal pyroptosis	Disease	MESH:D009410
39444090	2202	2206	HIBD	Disease	MESH:D002534
39444090	2207	2211	rats	Species	10116
39444090	2216	2221	NLRP3	Gene	287362
39444090	2222	2231	Caspase-1	Gene	25166
39444090	2232	2237	GSDMD	Gene	315084
39444090	2269	2273	PKM2	Gene	25630
39444090	2337	2377	neonatal ischemic-hypoxic encephalopathy	Disease	MESH:D020925
39444090	Association	MESH:D020925	25630
39444090	Association	MESH:D009410	315084
39444090	Association	MESH:D007249	25630
39444090	Association	MESH:D009410	25166
39444090	Negative_Correlation	MESH:C016101	MESH:D002534
39444090	Association	25630	287362
39444090	Association	25630	29197
39444090	Association	24494	25630
39444090	Association	MESH:D009410	25630
39444090	Negative_Correlation	MESH:C016101	25630
39444090	Association	MESH:D007249	29197
39444090	Positive_Correlation	25166	25630
39444090	Association	MESH:D002534	25630
39444090	Association	25630	315084
39444090	Association	MESH:D007249	24494
39444090	Association	MESH:D009410	287362

